Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition).
Saved in:
| Title: | Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). |
|---|---|
| Authors: | Zhao B; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhou X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zheng P; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang B; Department of Pharmacy, Peking Union Medical College Hospital, Beijing, China.; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China., Feng X; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China., Chen J; Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China., Cai L; Department of Hematology, Shenzhen Second People's Hospital, Shenzhen, China., Chen Y; Department of Pharmacy, Guangzhou Women and Children's Medical Center, Guangzhou, China., He L; Department of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou, China., Su J; Department of Pharmacy, Panyu Central Hospital, Guangzhou, China., Cheng S; Department of Hematology, Panyu Central Hospital, Guangzhou, China., Zeng Y; Department of Pharmacy, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou, China., Li G; Department of Hematology, Huizhou Central People's Hospital, Huizhou, China., Ji B; Department of Clinical Pharmacy, General Hospital of Southern Theatre Command of PLA, Guangzhou, China., Wu J; Department of Pharmacy, Shenzhen Second People's Hospital, Shenzhen, China., Feng W; Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China., Liu M; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China., Jin Y; Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Liu T; Pharmacy Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Mo X; Department of Pharmacy, Guangzhou Women and Children's Medical Center, Guangzhou, China., Wu J; Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China., Wu H; Department of Pharmacy, First Affiliated Hospital of Kunming Medical University, Kunming, China., Zhang H; Pharmacy Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Zheng Z; Department of Pharmacy, The Affiliated Hospital of Guizhou Medical University, Guiyang, China., Zheng Z; Guangdong Pharmaceutical Association, Guangzhou, China., Sun J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Li Y; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China. |
| Corporate Authors: | Guangdong Pharmaceutical Association, Hematology Group of Rare Disease Expert Committee of Guangdong Pharmaceutical Association |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 Nov 22; Vol. 15, pp. 1477550. Date of Electronic Publication: 2024 Nov 22 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2024.1477550 |
